A Study to Evaluate the Efficacy and Safety of Toripalimab Injection in the Treatment of Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy and Are Positive Specific Markers

Clinical trial NCT04603040 · TERMINATED

Trial details

NCT number: NCT04603040
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Recurrent or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma Who Have Failed at Least Two Prior Lines of Therapy

Start date: 2020-09-28
Primary completion: 2023-03-27
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.